>Year 2009, Issue 4
Padilla SL, Rodríguez-Trejo J, Escotto SI, Flores CJD, Rodríguez RN, Krötzsch GE, Villegas ÁF, Landero YT, Carranza CPH, Goldberg GJ, López MS
Progenitor mononuclear cell transplantation derived from de bone marrow through distal retrogressive endovenous route in order to induce angiogenesis in the lower members with ischemia
Cir Gen 2009; 31 (4)
PDF: 4. Kb.
Objective: To prove that autologous progenitor (stem) mononuclear cell transplantation derived from the bone marrow (PMC) through the distal femoral route in the ischemic extremity of rats generates higher angiogenesis and vasculogenesis than intramuscular transplantation.
Place: “20 de Noviembre” National Medical Center (third-level attention hospital).
Design: This was a prospective, comparative and randomized study.
Statistical analysis: Kruskal-Wallis test.
Material and methods: Thirty Sprague-Dawley rats were divided into three groups. Every animal was practiced an ischemia model. Groups N° 2 and N° 3 were applied the granulocyte colony-stimulating factor (G-CSF) at a dose of 5 mg per intramuscular kg during five days, followed by the aspiration of 3 ml of blood via cava vein puncture. The PMCs were obtained through the Ficoll gradient.
Group N° 1 – Ten rats that received saline solution through intramuscular route. Group N° 2 – Ten rats that received a transplantation of 3.4 X 105 ± 1.1 PMCs by intramuscular route.
Group N° 3 – Eight rats that received a transplantation of 3.4 X 105 ± 1.1 PMCs by distal endovenous route.
At 30 after the transplantation, it was practiced angiographies using a millimetric matrix in order to quantify the intersections of the neoformation vessels and determine the “angiographic index”.
Results: In group Nş 1, we obtained an average of 17 intersections; in group Nş 2, 21.5 intersections; and in group N° 3, 57 intersections (Stat. H = 17.58079 p = 0.0002)
Conclusion: Progenitor mononuclear cell (PMC) transplantation through endovenous route in the ischemic extremity of rats generates higher angiogenesis and vasculogenesis than by intramuscular route.
||Stem cell transplantation, angiogenesis, vasculogenesis, ischemia.
Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. Trans Atlantic Inter-Society Consensus (TASC). J Vasc Surg 2000; 31: S1-S278.
Rowlands TE, Donnelly R. Medical therapy for intermittent claudication. Eur J Vasc Endovasc Surg 2007; 34: 314-21.
Padilla-Sánchez L, Valle-González A, Sánchez-Cisneros R. Grafts of bovine arteries pre-treated with proteolytic enzymes into rats. Arch Inst Cardiol Mex 1983; 53: 91-8.
Padilla L, Sastre N, Chousleb A, Di Silvio M, Contreras M, Manzano B, et al. Polytetrafluoroethylene microprosthesis in the venous system of the rat. J Reconstr Microsurg 1987; 3: 159-63.
Padilla L, Valle A, Carrillo H, Di Silvio M, Contreras M, Viniegra F, et al. Polytetrafluoroethylene microprosthesis in the arterial system of the rat. J Reconstr Microsurg 1987; 4: 33-7.
Padilla SL, Chousleb KA, Di Silvio LM, Shultze RA, Ornelas L, Rocha HG. Injertos vasculares biológicos para microcirugía. Rev Fac Med (Mex) 1990; 33: 11-18.
Padilla SL, Chousleb KA, Di Silvio LM, Vázquez CJ, Chávez V, Rodríguez TJ. Microprótesis de politetrafluoroetileno de pared delgada. Rev Méx Angiol 1991; 19: 14-19.
Padilla SL, Carrillo-Soto IA, García GMV, Valdés GR. Angiogénesis inducida por túneles fibrocolágenos. Cir Gen 1996; 18: 123-8.
Pu LQ, Sniderman AD, Brassard R, Lachapelle KJ, Graham AM, Lisbona R, et al. Enhanced revascularization of the ischemic limb by angiogenic therapy. Circulation 1993; 88: 208-15.
Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 1992; 16: 181-91.
Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, et al. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg 1995; 21: 314-24.
Jackson CJ, Giles I, Knop A, Nethery A, Schrieber L. Sulfated polysaccharides are required for collagen-induced vascular tube formation. Exp Cell Res 1994; 215: 294-302.
Padilla SL, Figueroa BS, Carrillo SI, King AC, Schalch LP, Mollinedo RH. Angiogénesis inducida por colágena polivinilpirrolidona y heparina en el músculo isquémico. Cir Gen 1999; 67: 59-65.
Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003; 9: 702-12.
Padilla L, Krötzsch E, Schalch P, Figueroa S, Miranda A, Rojas E, et al. Administration of bone marrow cells into surgically induced fibrocollagenous tunnels induces angiogenesis in ischemic rat hindlimb model. Microsurgery 2003; 23: 568-74.
Padilla L, Krötzsch E, De La Garza AS, Figueroa S, Rodriguez-Trejo J, Avila G, et al. Bone marrow mononuclear cells stimulate angiogenesis when transplanted into surgically induced fibrocollagenous tunnels: results from a canine ischemic hindlimb model. Microsurgery 2007; 27: 91-7.
Goss JA, Soltes G, Goodpastor SE, Barth M, Lam R, Brunicardi FC, et al. Pancreatic islet transplantation: the radiographic approach. Transplantation 2003; 76: 199-203.
Bartsch T, Brehm M, Zeus T, Kögler G, Wernet P, Strauer BE. Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study). Clin Res Cardiol 2007; 96: 891-9.
Tepper OM, Capla JM, Galiano RD, Ceradini DJ, Callaghan MJ, Kleinman ME, et al. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 2005; 105: 1068-77.
>Year 2009, Issue 4